Cover Image
市場調查報告書

家庭點滴療法市場預測 2013-2024年:各產品 (輸液幫浦,靜脈注射套組,靜脈注射針頭,無針式接頭),各用途,及各市場區隔分析

Home Infusion Therapy Market Analysis By Product (Infusion Pumps, IV Sets, IV Cannulas, Needleless Connectors), By Application (Anti-Infectives, Endocrinology, Hydration Therapy, Parenteral Nutrition), And Segment Forecasts, 2013 - 2024

出版商 Grand View Research, Inc. 商品編碼 342348
出版日期 內容資訊 英文 100 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
家庭點滴療法市場預測 2013-2024年:各產品 (輸液幫浦,靜脈注射套組,靜脈注射針頭,無針式接頭),各用途,及各市場區隔分析 Home Infusion Therapy Market Analysis By Product (Infusion Pumps, IV Sets, IV Cannulas, Needleless Connectors), By Application (Anti-Infectives, Endocrinology, Hydration Therapy, Parenteral Nutrition), And Segment Forecasts, 2013 - 2024
出版日期: 2016年12月23日 內容資訊: 英文 100 Pages
簡介

全球家庭點滴療法市場預計至2024年達到283億美元。由於醫療費的驟漲,在長期照護必要的患者之間,選擇家庭點滴療法的比率高漲。

本報告提供全球家庭點滴療法市場相關分析,各產品,各用途預測,以及各地區趨勢等彙整資料。

第1章 調查方法與調查範圍

第2章 摘要整理

第3章 家庭點滴療法產業預測

  • 市場區隔
  • 市場規模與成長預測
  • 市場趨勢
    • 促進要素
    • 阻礙要素
  • 被優先的主要的機會
  • 產業分析:波特
  • PESTEL分析

第4章 產品預測

  • 各產品市場佔有率
  • 輸液幫浦
  • 靜脈注射套組
  • 靜脈注射針頭
  • 無針式接頭

第5章 各用途預測

  • 各用途市場佔有率
  • 抗發炎
  • 分泌學
  • 水和療法
  • 化療
  • 經腸營養
  • 非口服營養
  • 特殊醫藥品
  • 其他

第6章 各地區預測

  • 各地區市場佔有率
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東、非洲

第7章 競爭環境

  • B. Braun Melsungen
  • Baxter Inc
  • Caesarea Medical Electronics
  • CareFusion Corporation
  • Fresenius Kabi
  • ICU Medical Inc.
  • JMS Co. Ltd.
  • Smiths Medical
  • Terumo Corporation

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 978-1-68038-389-8

The global home infusion therapy market is expected to be USD 28.3 billion by 2024, based on a new report by Grand View Research, Inc. Increasing need to contain the soaring healthcare costs has led to a higher preference for home infusion therapies amongst patients requiring long-term care.

The growing healthcare expenditure level is a key concern amongst patients and governments worldwide, necessitating the implementation of effective measures to curb these costs. Hence, the home healthcare option serves as a cost-effective alternative to expensive hospital stays, which is expected to serve this market as a high impact rendering driver throughout the forecast period. Moreover, increasing awareness about the high prevalence of hospital-acquired infections is anticipated to accentuate the importance of home healthcare.

Currently, the major chronic diseases, such as cancer, diabetes, respiratory disorders, cardiovascular diseases, and other life threatening diseases, account for 60% of the total death count and 43% of the global disease burden. The administration of medication in the home setting provides several advantages to patients, which include faster recovery, greater comfort, fewer complications, cost savings, and others. This is expected to drive the growth of the market in the near future.

Further Key Findings From The Study Suggest:

  • The product segment was dominated by infusion pumps with a market share of around 45.0% in 2015 owing to the greater number of initiatives conducted by the key players pertaining to new product development.
  • Needleless connectors are projected to witness the highest CAGR over the forecast period owing to greater benefits associated with their use in comparison to needle connectors.
  • Anti-infectives segment contributed to the largest market revenue in 2015. This is mainly due to the fact that it is frequently employed for patients in homecare settings.
  • Chemotherapy segment is anticipated to exhibit the highest CAGR of over 9.0% over the forecast period, which is attributable to technological advancements that render their usage convenient.
  • Use of injectable drug therapy in endocrinology is also estimated to gain lucrative growth over the forecast period owing to increasing awareness levels of insulin pumps among patients and healthcare providers.
  • North America dominated the market in 2015 with revenue of around USD 5.0 billion. Rising government programs and initiatives to promote awareness pertaining to the benefits of home infusion therapy have resulted in the higher revenue generation in this region
  • Strategic collaborations, regional expansion efforts, and mergers and acquisitions are some of the foremost strategies adopted by the key players. For instance, in January 2014, Terumo Corporation signed an eight-year agreement to collaboratively market, distribute, and co-brand their peripheral I.V. catheter series with CareFusion Corporation.

Table of Contents

Chapter 1: Research Methodology & Scope

  • 1.1. Information procurement
    • 1.1.1. Purchased database:
    • 1.1.2. GVR's Internal Database
  • 1.2. Research Methodology
  • 1.3. Geographic Scope & Assumptions
  • 1.4. Region Wise Market Calculation
    • 1.4.1. Region Wise Market: Base Estimates
    • 1.4.2. Global Market: CAGR Calculation
  • 1.5. Region-based segment share calculation
  • 1.6. List of Secondary Sources

Chapter 2: Executive Summary

  • 2.1. Market Snapshot

Chapter 3: Home Infusion Therapy Industry Outlook

  • 3.1. Market Segmentation
  • 3.2. Market size and growth prospects
  • 3.3. Home infusion therapy Market Dynamics
    • 3.3.1. Market driver analysis
      • 3.3.1.1. Growing geriatric population base
      • 3.3.1.2. Rising prevalence of chronic disorders
      • 3.3.1.3. Rapid technological advancements
      • 3.3.1.4. Growing incidence of hospital acquired infections
      • 3.3.1.5. Home healthcare as cost effective alternative
    • 3.3.2. Market restraint analysis
      • 3.3.2.1. Presence of complicated reimbursement framework and reimbursement cuts
  • 3.4. Key Opportunities Prioritized
  • 3.5. Industry Analysis Porter's
  • 3.6. Home Infusion Therapy PESTEL Analysis

Chapter 4: Home Infusion Therapy Market: Product Estimates & Trend Analysis

  • 4.1. Home infusion therapy market share by product, 2015& 2024
  • 4.2. Infusion pumps
    • 4.2.1. Infusion pumps market, 2013-2024(USD Million)
  • 4.3. Intravenous Sets
    • 4.3.1. Intravenous sets market, 2013-2024(USD Million)
  • 4.4. IV cannulas
    • 4.4.1. IV cannulas market, 2013-2024(USD Million)
  • 4.5. Needleless connectors
    • 4.5.1. Needleless connectors market, 2013-2024(USD Million)

Chapter 5: Home Infusion Therapy Market: Application Estimates & Trend Analysis

  • 5.1. Home infusion therapy market share by application, 2015 & 2024
  • 5.2. Anti-Infective
    • 5.2.1. Anti-Infective market, 2013-2024(USD Million)
  • 5.3. Endocrinology
    • 5.3.1. Endocrinology market, 2013-2024(USD Million)
  • 5.4. Hydration Therapy
    • 5.4.1. Hydration therapy market, 2013-2024(USD Million)
  • 5.5. Chemotherapy
    • 5.5.1. Chemotherapy market, 2013-2024(USD Million)
  • 5.6. Enteral Nutrition
    • 5.6.1. Enteral nutrition market, 2013-2024(USD Million)
  • 5.7. Parenteral Nutrition
    • 5.7.1. Parenteral nutrition market, 2013-2024(USD Million)
  • 5.8. Specialty Pharmaceuticals
    • 5.8.1. Specialty pharmaceuticals market, 2013-2024(USD Million)
  • 5.9. Others
    • 5.9.1. Others market, 2013-2024(USD Million)

Chapter 6: Home Infusion Therapy Market: Regional Outlook

  • 6.1. Home infusion therapy market share, by region, 2015 & 2024
  • 6.2. North America
    • 6.2.1. North America home infusion therapy market estimates and forecasts, 2013-2024
    • 6.2.2. U.S.
    • 6.2.3. U.S. home infusion therapy market estimates and forecasts, 2013-2024
    • 6.2.4. Canada
    • 6.2.5. Canada home infusion therapy market estimates and forecasts, 2013-2024
  • 6.3. Europe
    • 6.3.1. Europe home infusion therapy market estimates and forecasts, 2013-2024
    • 6.3.2. Germany
    • 6.3.3. Germany home infusion therapy market estimates and forecasts, 2013-2024
    • 6.3.4. UK
    • 6.3.5. UK home infusion therapy market estimates and forecasts, 2013-2024
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific home infusion therapy market estimates and forecasts2013-2024
    • 6.4.2. Japan
    • 6.4.3. Japan home infusion therapy market estimates and forecasts, 2013-2024
    • 6.4.4. China
    • 6.4.5. China home infusion therapy market estimates and forecasts, 2013-2024
  • 6.5. Latin America
    • 6.5.1. Latin America home infusion therapy market estimates and forecasts, 2013-2024
    • 6.5.2. Brazil
    • 6.5.3. Brazil home infusion therapy market estimates and forecasts, 2013-2024
    • 6.5.4. Mexico
    • 6.5.5. Mexico home infusion therapy market estimates and forecasts, 2013-2024
  • 6.6. Middle East and Africa
    • 6.6.1. Middle East and Africa home infusion therapy market estimates and forecasts, 2013-2024(USD Million)
    • 6.6.2. South Africa
    • 6.6.3. South Africa home infusion therapy market estimates and forecasts, 2013-2024

Chapter 7: Competitive Landscape

  • 7.1. B. Braun Melsungen AG
    • 7.1.1. Company Overview
    • 7.1.2. Financial Performance
    • 7.1.3. Product Benchmarking
    • 7.1.4. Strategic Initiatives
  • 7.2. Baxter Inc.
    • 7.2.1. Company Overview
    • 7.2.2. Financial Performance
    • 7.2.3. Product Benchmarking
    • 7.2.4. Strategic Initiatives
  • 7.3. Caesarea Medical Electronics
    • 7.3.1. Company Overview
    • 7.3.2. Financial Performance
    • 7.3.3. Product Benchmarking
    • 7.3.4. Strategic Initiatives
  • 7.4. CareFusion Corporation
    • 7.4.1. Company Overview
    • 7.4.2. Financial Performance
    • 7.4.3. Product Benchmarking
    • 7.4.4. Strategic Initiatives
  • 7.5. Fresenius Kabi
    • 7.5.1. Company Overview
    • 7.5.2. Financial Performance
    • 7.5.3. Product Benchmarking
    • 7.5.4. Strategic Initiatives
  • 7.6. ICU Medical Inc.
    • 7.6.1. Company Overview
    • 7.6.2. Financial Performance
    • 7.6.3. Product Benchmarking
    • 7.6.4. Strategic Initiatives
  • 7.7. JMS Co. Ltd.
    • 7.7.1. Company Overview
    • 7.7.2. Financial Performance
    • 7.7.3. Product Benchmarking
    • 7.7.4. Strategic Initiatives
  • 7.8. Smiths Medical
    • 7.8.1. Company Overview
    • 7.8.2. Financial Performance
    • 7.8.3. Product Benchmarking
    • 7.8.4. Strategic Initiatives
  • 7.9. Terumo Corporation
    • 7.9.1. Company Overview
    • 7.9.2. Financial Performance
    • 7.9.3. Product Benchmarking
    • 7.9.4. Strategic Initiatives

List of Tables

  • TABLE 1: Country share estimation
  • TABLE 2: Home Infusion Therapy - Key market driver analysis
  • TABLE 3: Home Infusion Therapy - Key market restraint analysis
  • TABLE 4: North America home infusion therapy market, by product, 2013 - 2024 (USD Million)
  • TABLE 5: North America home infusion therapy market, by application, 2013 - 2024 (USD Million)
  • TABLE 6: U.S. home infusion therapy market, by product, 2013 - 2024 (USD Million)
  • TABLE 7: U.S. home infusion therapy market, by application, 2013 - 2024 (USD Million)
  • TABLE 8: Canada home infusion therapy market, by product, 2013 - 2024 (USD Million)
  • TABLE 9: Canada home infusion therapy market, by application, 2013 - 2024 (USD Million)
  • TABLE 10: Europe home infusion therapy market, by product, 2013 - 2024 (USD Million)
  • TABLE 11: Europe home infusion therapy market, by application, 2013 - 2024 (USD Million)
  • TABLE 12: Germany home infusion therapy market, by product, 2013 - 2024 (USD Million)
  • TABLE 13: Germany home infusion therapy market, by application, 2013 - 2024 (USD Million)
  • TABLE 14: UK home infusion therapy market, by product, 2013 - 2024 (USD Million)
  • TABLE 15: UK home infusion therapy market, by application, 2013 - 2024 (USD Million)
  • TABLE 16: Asia Pacific home infusion therapy market, by product, 2013 - 2024 (USD Million)
  • TABLE 17: Asia Pacific home infusion therapy market, by application, 2013 - 2024 (USD Million)
  • TABLE 18: Japan home infusion therapy market, by product, 2013 - 2024 (USD Million)
  • TABLE 19: Japan home infusion therapy market, by application, 2013 - 2024 (USD Million)
  • TABLE 20: China home infusion therapy market, by product, 2013 - 2024 (USD Million)
  • TABLE 21: China home infusion therapy market, by application, 2013 - 2024 (USD Million)
  • TABLE 22: Latin America home infusion therapy market, by product, 2013 - 2024 (USD Million)
  • TABLE 23: Latin America home infusion therapy market, by application, 2013 - 2024 (USD Million)
  • TABLE 24: Brazil home infusion therapy market, by product, 2013 - 2024 (USD Million)
  • TABLE 25: Brazil home infusion therapy market, by application, 2013 - 2024 (USD Million)
  • TABLE 26: Mexico home infusion therapy market, by product, 2013 - 2024 (USD Million)
  • TABLE 27: Mexico home infusion therapy market, by application, 2013 - 2024 (USD Million)
  • TABLE 28: MEA home infusion therapy market, by product, 2013 - 2024 (USD Million)
  • TABLE 29: Middle East and Africa home infusion therapy market, by application, 2013 - 2024 (USD Million)
  • TAsBLE 3: South Africa home infusion therapy market, by product, 2013 - 2024 (USD Million)
  • TABLE 31: South Africa home infusion therapy market, by application, 2013 - 2024 (USD Million)

List of Figures

  • FIG. 1: Market research process
  • FIG. 2: Information procurement
  • FIG. 3: Market summary
  • FIG. 4: Home Infusion Therapy: Market Segmentation
  • FIG. 5: Home infusion therapy market revenue, (USD Million), 2013-2024
  • FIG. 6: Home Infusion: Market Dynamics
  • FIG. 7: Key Opportunities Prioritized
  • FIG. 8: Home infusion therapy Porter's analysis
  • FIG. 9: Home infusion therapy - PESTEL analysis
  • FIG. 10: Global home infusion therapy market share, by product, 2015 & 2024
  • FIG. 11: Infusion pumps market, 2013 - 2024 (USD Million)
  • FIG. 12: Intravenous sets market, 2013 - 2024 (USD Million)
  • FIG. 13: IV cannulas market, 2013 - 2024 (USD Million)
  • FIG. 14: Needleless connectors market, 2013 - 2024 (USD Million)
  • FIG. 15: Global home infusion therapy market share, by application, 2015 & 2024
  • FIG. 16: Anti-Infective market, 2013 - 2024 (USD Million)
  • FIG. 17: Endocrinology market, 2013 - 2024 (USD Million)
  • FIG. 18: Hydration therapy market, 2013 - 2024 (USD Million)
  • FIG. 19: Chemotherapy market, 2013 - 2024 (USD Million)
  • FIG. 20: Enteral nutrition market, 2013 - 2024 (USD Million)
  • FIG. 21: Parenteral nutrition market, 2013 - 2024 (USD Million)
  • FIG. 22: Specialty pharmaceuticals market, 2013 - 2024 (USD Million)
  • FIG. 23: Others market, 2013 - 2024 (USD Million)
  • FIG. 24: Home infusion therapy market share, by region, 2015 & 2024
  • FIG. 25: North America home infusion therapy market, by application, 2013 - 2024 (USD Million)
  • FIG. 26: U.S. home infusion therapy market, by application, 2013 - 2024 (USD Million)
  • FIG. 27: Canada home infusion therapy market, by application, 2013 - 2024 (USD Million)
  • FIG. 28: Europe home infusion therapy market, by application, 2013 - 2024 (USD Million)
  • FIG. 29: Germany home infusion therapy market, 2013 - 2024 (USD Million)
  • FIG. 30: UK home infusion therapy market,2013 - 2024 (USD Million)
  • FIG. 31: Asia Pacific home infusion therapy market,,2013 - 2024 (USD Million)
  • FIG. 32: Japan home infusion therapy market, 2013 - 2024 (USD Million)
  • FIG. 33: China home infusion therapy market, by application, 2013 - 2024 (USD Million)
  • FIG. 34: Latin America home infusion therapy market, by application, 2013 - 2024 (USD Million)
  • FIG. 35: Brazil home infusion therapy market, by application, 2013 - 2024 (USD Million)
  • FIG. 36: Mexico home infusion therapy market, by application, 2013 - 2024 (USD Million)
  • FIG. 37: Middle East and Africa home infusion therapy market, by application, 2013 - 2024 (USD Million)
  • FIG. 38: South Africa home infusion therapy market, by application, 2013 - 2024 (USD Million)
Back to Top